Search

everythinglearnresearchcommunity

for

Search:↓

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transgender and gender-diverse teens need specialized skin and mental health care.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Facial gender surgery techniques focus on forehead and hairline changes for accurate results.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

More research is needed to improve lower body gender affirmation techniques.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.